Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology/Urology
Disease Category: Kidney Cancer
Trial Information
Development of a Blood Test of Anti-IMP3 Autoantibody for the Detection of Renal Cell Carcinoma with Metastasis and Metastatic Potential
You have been asked to participate in this research study because you have been diagnosed with or are suspected to have renal cell carcinoma (RCC) (kidney cancer). The purpose of this study is to develop a blood test to detect whether RCC has metastasized (spread into other organ(s)). Your participation on this study is expected to last as long as it takes to draw additional blood at the time of your routine blood test(s) before surgery.
Patient Inclusion/Exclusion Criteria:
- See http://clinicaltrials.coh.org for additional information.
City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)
View Google Map
Research Center Information: City of Hope
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
